Tag Archives: Allergan

Pfallergan Round II?

<<Trump Executive Order Could Revive Allergan-Pfizer Merger -Emily Stewart   TheStreet.com    April 22,  2017 The Trump administration’s executive order on tax regulations could revive the defunct Allergan-Pfizer merger. The White House on Friday unveiled a new executive order instructing the Treasury … Continue reading

Posted in Big Pharma, BioFollies | Tagged , , , | 1 Comment

Assorted Interim Comments

1) Scott Gottlieb as FDA Commissioner: Gottlieb was Deputy Commissioner during the all-too-brief tenure of Mark McClellan, and we have followed his commentaries with interest and generally with agreement over the past decade+. We do believe that he has more … Continue reading

Posted in Big Pharma, Biotech, Muddled Media | Tagged , , , , , , , , | Leave a comment

Allergan Gets It Right

It had seemed for a while that the headlines only reinforced the common public perception that the pharma industry had devolved into a snake pit of self-centered greed. Led by the Three Horsemen of the Pharmapocalypse, Shkreli, Pearson, and Bresch … Continue reading

Posted in Big Pharma, Biotech | Tagged , , , , , , | Leave a comment

A Fond Farewell to My Cali-Irish Lass

My Dearest Allergan: The last few months have felt like a dream–you and I idling away the hours by the Irish Sea, picking out a spot for our new corporate cottage, singing the names of the staff we were going … Continue reading

Posted in Big Pharma | Tagged , , | 2 Comments

A Thanksgiving Message from Pfallergan

As the United States prepares to celebrate Thanksgiving, a holiday that traditionally mixes gratitude and gluttony in relatively even proportions, we at Pfallergan would like to say how grateful we are for the fortuitous conjoining of our two constituent companies. … Continue reading

Posted in Big Pharma | Tagged , , | Leave a comment

The Pfallergan Phallacy

(from NP Nov-Dec, released 10/31/15) As this issue of NP is released, the business media world is all aflutter with news that Pfizer and Allergan are discussing a merger. The headlines emphasize the massive scale of the potential alliance and … Continue reading

Posted in Big Pharma, BioFollies | Tagged , , | Leave a comment

Naurex

Over the weekend, Naurex announced that it had been acquired by Allergan (Actavis/Forest) for $560 million plus undisclosed milestones; Allergan is focused upon Naurex’s two clinical-stage Rapid-Acting-Antidepressant candidates, IV rapastinel/GlyX-13, and orally-bioavailable NRX-1074. NIR has been following this particular technology … Continue reading

Posted in Big Pharma, Biotech | Tagged , , , | Leave a comment